Results 1 - 10 of 1589

< 1 2 3 ... 158 159 >

• N. Venu, P. Vishweshwar, T. Ram, D. Surya and B. Apurba. (S)-3-(Ammoniomethyl)-5-methylhexanoate (pregabalin), Acta Cryst. (2007). C63, o306-o308    

  [PubMed: 17478919]
  [DOI: 10.1107/S0108270107016952]
  
• Peter J. Dunn. The importance of Green Chemistry in Process Research and Development, Chem. Soc. Rev., 2012, 41, 1452.

  [PubMed: 21562677]
  [DOI: 10.1039/c1cs15041c]
  
• Jae-Hoon Jung, Doo-Ha Yoon, Philjun Kang, Won Koo Lee, Heesung Eum and Hyun-Joon Ha. CAL-B catalyzed desymmetrization of 3-alkylglutarate: “olefin effect” and asymmetric synthesis of pregabalin, Org. Biomol. Chem., 2013, 11, 3635.

  [PubMed: 23525234]
  [DOI: 10.1039/c3ob40311d]
  
• Blakemore DC; Bryans JS; Carnell P; Chessum NE; Field MJ; Kinsella N; Kinsora JK; Osborne SA; Williams SC. Synthesis and in vivo evaluation of 3-substituted gababutins., Bioorganic & medicinal chemistry letters

  [PubMed: 19897364]
  [DOI: 10.1016/j.bmcl.2009.10.089]
  
• Schelkun RM; Yuen PW; Wustrow DJ; Kinsora J; Su TZ; Vartanian MG. Heteroaromatic side-chain analogs of pregabalin., Bioorganic & medicinal chemistry letters

  [PubMed: 16099652]
  [DOI: 10.1016/j.bmcl.2005.06.090]
  
• Barrondo S; Sall?s J. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies., Neuropharmacology

  [PubMed: 18951909]
  [DOI: 10.1016/j.neuropharm.2008.09.0]
  
• Altamura AC; Moliterno D; Paletta S; Maffini M; Mauri MC; Bareggi S. Understanding the pharmacokinetics of anxiolytic drugs., Expert opinion on drug metabolism & toxicology

  [PubMed: 23330992]
  [DOI: 10.1517/17425255.2013.759209]
  
• Tattoli L; Krocker K; Sautter J; Tsokos M. Multidrug-related leukocytoclastic vasculitis raising suspicion of sexual homicide-things are not always what they seem., International journal of legal medicine

  [PubMed: 25957602]
  [DOI: 10.1007/s00414-015-1202-6]
  
• Oulis P; Nakkas G; Masdrakis VG. Pregabalin in zolpidem dependence and withdrawal., Clinical neuropharmacology

  [PubMed: 21407000]
  [DOI: 10.1097/WNF.0b013e31820a3b5a]
  
• Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition., Neuropharmacology

  [PubMed: 17904589]
  [DOI: 10.1016/j.neuropharm.2007.08.0]